Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Arteriosclerosis and Thrombosis A Journal of Vascular Biology

• Publication date

  1991-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1161/01.ATV.11.5.1209PMID 1911707
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophage degradation of LDL extracted from human aortic plaques: effect of isolation conditions.

  1991cited by this paper
• Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I.

  1990cited by this paper
• Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits.

  1990cited by this paper
• Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.

  1990cited by this paper
• Low density lipoprotein interaction with artery derived proteoglycan: the influence of LDL particle size and the relationship to atherosclerosis susceptibility.

  1989cited by this paper
• Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages.

  1989cited by this paper
• Low density lipoprotein undergoes oxidative modification in vivo.

  1989cited by this paper
• Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.

  1989cited by this paper
• Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

  1989cited by this paper
• Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching.

  1989cited by this paper
• A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein.

  1989cited by this paper
• Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation.

  1989cited by this paper
• Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins.

  1989cited by this paper
• Enhanced Macrophage Uptake of Low Density Lipoprotein after Self‐Aggregation

  1988cited by this paper
• Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits.

  1988cited by this paper
• Modified plasma-derived lipoproteins in human atherosclerotic plaques.

  1988cited by this paper
• Stimulated arachidonate metabolism during foam cell transformation of mouse peritoneal macrophages with oxidized low density lipoprotein.

  1988cited by this paper
• Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima.

  1988cited by this paper
• Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits.

  1988cited by this paper
• Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages.

  1988cited by this paper
• Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products.

  1987cited by this paper
• Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications.

  1987cited by this paper
• Effects of cytochalasin and phalloidin on actin

  1987cited by this paper
• Decrease in Reactive Amino Groups during Oxidation or Endothelial Cell Modification of LDL: Correlation with Changes in Receptor‐Mediated Cataboiism

  1987cited by this paper
• Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100.

  1987cited by this paper
• Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes.

  1987cited by this paper
• Uptake of canine beta-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor.

  1986cited by this paper
• A low density lipoprotein-sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger-receptor mechanism.

  1986cited by this paper
• Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal.

  1986cited by this paper
• Measurement of protein using bicinchoninic acid.

  1985cited by this paper
• Cholesterol esterification in macrophages. Stimulation by lipoproteins containing apo B isolated from human aortas.

  1984cited by this paper
• Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

  1983cited by this paper
• Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins.

  1982influential reference
• Isolation, purification, and characterization of a lipoprotein containing Apo B from the human aorta.

  1982cited by this paper
• The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions.

  1981cited by this paper
• The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions.

  1981cited by this paper
• Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.

  1979cited by this paper
• Characterization of low density lipoprotein-like particle in the human aorta from grossly normal and atherosclerotic regions.

  1979cited by this paper
• Correlation of apolipoprotein B retention with the structure of atherosclerotic plaques from human aortas.

  1978cited by this paper
• Detergent extraction of tightly-bound apoB from extracts of normal aortic intima and plaques.

  1978cited by this paper
• Apo B concentration in the normal human aorta.

  1978cited by this paper
• Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.

  1978cited by this paper
• Ultrastructural localization of apolipoprotein B in human aortic and coronary atherosclerotic plaques.

  1977cited by this paper
• The low-density lipoprotein pathway and its relation to atherosclerosis.

  1977cited by this paper
• Ultrastructural localization of plasma lipoproteins in human intracranial arteries

  1975cited by this paper
• Enzymatische Bestimmung des Gesamt-Cholesterins im Serum

  1974cited by this paper
• Interaction of phosphatidylcholine and apolipoprotein-alanine: electron microscopic studies.

  1973cited by this paper
• Relationship between low-density lipoprotein in aortic intima and serum-lipid levels.

  1972cited by this paper
• The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

  1972cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Practical methods for plasma lipoprotein analysis.

  1968cited by this paper
• Fatty streaks in the coronary arteries and aorta.

  1968influential reference
• Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.

  1966cited by this paper
• Efficient Trace-labelling of Proteins with Iodine

  1958cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Single-aggregate morphological and biomechanical detection of atherogenic aggregated low-density lipoprotein (agLDL) by atomic force microscopy.

  2025cites this paper
• The Association Between Arsenic Levels and Oxidative Stress in Myocardial Infarction: A Case–Control Study

  2023cites this paper
• Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases

  2020cites this paper
• Honey Intake and Risk of CVDs: A Mechanistic Disclosure

  2020cites this paper
• Lipid efflux mechanisms, relation to disease and potential therapeutic aspects.

  2020cites this paper
• Malondialdehyde epitopes as mediators of sterile inflammation.

  2017cites this paper
• Fatty Acid Composition and Vitamin E Content of Experimental Diets Component Study Diet Oleic Linoleic Oleic

  2017cites this paper
• Honey-derived flavonoids: natural products for the prevention of atherosclerosis and cardiovascular diseases

  2016cites this paper
• In-flight piv for cror flight test demonstration

  2016cites this paper
• Aggregation and fusion of low-density lipoproteins in vivo and in vitro

  2013cites this paper
• Evaluation of the effects of weak and moderate static magnetic fields on the characteristics of human low density lipoprotein in vitro

  2013cites this paper
• Molecular and Cellular Effects of Nutrition on Disease Processes

  2012cites this paper
• Role of NKT cell activation in malondialdehyde-modified low density lipoprotein immunization for atherosclerosis prevention

  2012cites this paper
• Lipid loading of human vascular smooth muscle cells induces changes in tropoelastin protein levels and physical structure.

  2012cites this paper
• C-reactive protein induced rearrangement of phosphatidylcholine on nanoparticle mimics of lipoprotein particles.

  2010cites this paper
• Size-selective uptake of colloidal low density lipoprotein aggregates by cultured white blood cells.

  2010cites this paper
• Differential expression of cytokines, chemokines and chemokine receptors in patients with coronary artery disease.

  2009cites this paper
• Proteomic approach to study the effects of various oxidatively modified low-density lipoprotein on regulation of protein expression in human umbilical vein endothelial cell.

  2007cites this paper
• Oxidation-induced aggregation of LDL increases their uptake by smooth muscle cells from human aorta

  2007cites this paper
• Effect of lysosomal cholesterol accumulation on lysosomal and vacuolar-ATPase activity

  2007cites this paper
• Genetic variation within the IL-18 system and its association with cardiovascular disease and obesity.

  2007cites this paper
• Oxidized LDL and Antioxidants in Atherosclerosis

  2006cites this paper
• Selective proteolysis of apolipoprotein B-100 by Arg-gingipain mediates atherosclerosis progression accelerated by bacterial exposure.

  2006cites this paper
• L'INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE LYON

  2006cites this paper
• Interplay between lipoproteins and bee venom phospholipase A2 in relation to their anti-plasmodium toxicity Published, JLR Papers in Press, April 10, 2006.

  2006cites this paper
• 125I-Low Density Lipoproteins in Rabbit Arteries

  2005cites this paper
• [Low-density lipoproteins with different capacity for aggregation].

  2005cites this paper
• Aggregated LDL and Lipid Dispersions Induce Lysosomal Cholesterol Accumulation in Macrophage Foam Cells

  2005cites this paper
• Intracellular lipid accumulation, low‐density lipoprotein receptor‐related protein expression, and cell survival in vascular smooth muscle cells derived from normal and atherosclerotic human coronaries

  2004cites this paper
• Differences in human antioxidized LDL autoantibodies in patients with stable and unstable angina.

  2004cites this paper
• Cysteine Protease Cathepsin F Is Expressed in Human Atherosclerotic Lesions, Is Secreted by Cultured Macrophages, and Modifies Low Density Lipoprotein Particles in Vitro*

  2004cites this paper
• HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages.

  2003cites this paper
• Hydrolytic enzymes released from resident macrophages and located in the intima extracellular matrix as agents that modify retained apolipoprotein B lipoproteins.

  2003cites this paper
• Oxidation affects the flow-induced aggregation of low density lipoprotein and its inhibition by albumin.

  2003cites this paper
• Different mechanisms of adhesion molecule expression in human dermal microvascular endothelial cells by xanthoma tissue-mediated and copper-mediated oxidized low density lipoproteins.

  2003cites this paper
• Effect of fluid mechanical stresses and plasma constituents on aggregation of LDL Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200477-JLR200

  2003cites this paper
• Inhibition of THP-1 cell-mediated low-density lipoprotein oxidation by the macrophage-synthesised pterin, 7,8-dihydroneopterin

  2003cites this paper
• 7,8-dihydroneopterin inhibition of oxidised low density lipoprotein-induced cellular death

  2003cites this paper
• Cyclooxygenase-2 Is Induced in Monocytes by Peroxisome Proliferator Activated Receptor γ and Oxidized Alkyl Phospholipids from Oxidized Low Density Lipoprotein*

  2002cites this paper
• Assay methods of modified lipoproteins in plasma.

  2002cites this paper
• Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans.

  2002cites this paper
• Wine Flavonoids Protect against LDL Oxidation and Atherosclerosis

  2002cites this paper
• Hypercholesterolemia impairs vascular remodelling after porcine coronary angioplasty.

  2002cites this paper
• Partial e haracterizat ion of I i poprotei ns containing apo [ a ] in human atherosclerotic lesions

  2002cites this paper
• Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein. Influences of degree of oxidation and location of oxidized LDL.

  2001cites this paper
• Oxidized low density lipoprotein-induced inhibition of processing of photoreceptor outer segments by RPE.

  2001cites this paper
• Myeloperoxidase and Hypochlorite, but Not Copper Ions, Oxidize Heparin-Bound LDL Particles and Release Them From Heparin

  2001cites this paper
• Cellular immunity and inflammation in atherosclerosis

  2001cites this paper
• Oxidized Alkyl Phospholipids Are Specific, High Affinity Peroxisome Proliferator-activated Receptor γ Ligands and Agonists*

  2001cites this paper
• Macrophage foam cells and atherosclerosis.

  2001cites this paper
• Polyphenols and Flavonoids Protect LDL Against Atherogenic Modifications

  2001cites this paper
• Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications.

  2001cites this paper
• Altered phospholipid-apoB-100 interactions and generation of extra membrane material in proteolysis-induced fusion of LDL particles.

  2001cites this paper
• Antioxidative and Antiatherosclerotic Effects of Human Apolipoprotein A-IV in Apolipoprotein E-Deficient Mice

  2001cites this paper
• LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells.

  2000cites this paper
• Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions.

  2000cites this paper
• Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient mice.

  2000cites this paper
• Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL.

  2000cites this paper
• Basic research Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient mice

  2000cites this paper
• HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques.

  2000cites this paper
• Modified LDL – trigger of atherosclerosis and inflammation in the arterial intima

  2000cites this paper
• Mechanisms of LDL Oxidation

  2000cites this paper
• Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM‐CSF and CSF‐1

  2000cites this paper
• Plasmin-mediated Macrophage Reversal of Low Density Lipoprotein Aggregation*

  2000cites this paper
• Direct evidence for apo B-100-mediated copper reduction: studies with purified apo B-100 and detection of tryptophanyl radicals.

  2000cites this paper
• Simpler technique for measuring oxidative susceptibility by heparin affinity column isolation of lipoproteins.

  1999cites this paper
• Lipolytic modification of LDL by phospholipase A2 induces particle aggregation in the absence and fusion in the presence of heparin.

  1999cites this paper
• Quantitative immunohistochemical detection of oxidized low density lipoprotein in the rabbit arterial wall.

  1999cites this paper
• Coexistence of oxidized lipids and alpha-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques.

  1999cites this paper
• Apolipoprotein B Stimulates Formation of Monocyte-Macrophage Surface-connected Compartments and Mediates Uptake of Low Density Lipoprotein-derived Liposomes into these Compartments*

  1999cites this paper
• Role of oxidatively modified low density lipoproteins and anti-oxidants in atherothrombosis.

  1999cites this paper
• Nonoxidative modifications of lipoproteins in atherogenesis.

  1999cites this paper
• Different apolipoprotein B breakdown patterns in models of oxidized low density lipoprotein.

  1999cites this paper
• Macrophage released proteoglycans are involved in cell-mediated aggregation of LDL.

  1999cites this paper
• Macrophages LDLs in Human Blood Monocytes During the Early Stage of Differentiation Into Lovastatin Decreases the Receptor-Mediated Degradation of Acetylated and Oxidized

  1999cites this paper
• Retention and Accumulation of Low Density Lipoprotein Particles in the Extracellular Matrix of the Arterial Intima in Atherogenesis

  1999cites this paper
• Lovastatin decreases the receptor-mediated degradation of acetylated and oxidized LDLs in human blood monocytes during the early stage of differentiation into macrophages.

  1999cites this paper
• ANTIATHEROGENICITY AND ANTIOXIDATIVE PROPERTIES OF POLYPHENOLIC FLAVONOIDS AGAINST LDL OXIDATION

  1999cites this paper
• Relationship between lipoprotein- and oxidation-related variables and atheroma lipid composition in subjects undergoing coronary artery bypass graft surgery.

  1999cites this paper
• LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants

  1998cites this paper
• FATTY ACIDS | Monounsaturated*

  1998cites this paper
• Site-specific effect of radical scavengers on the resistance of low density lipoprotein to copper-mediated oxidative stress: influence of alpha-tocopherol and temperature.

  1998cites this paper
• Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis.

  1998cites this paper
• Preparation of a Human Standard for Determination of the Levels of Antibodies to Oxidatively Modified Low-Density Lipoproteins

  1998cites this paper
• Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis.

  1998cites this paper
• Is oxidized low-density lipoprotein present in vivo?

  1998cites this paper
• In vivo oxidized low desinty lipoprotein: Degree of lipoprotein oxidation does not correlate with its atherogenic properties

  1998cites this paper
• Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors.

  1998cites this paper
• Lipoproteins to Oxidatively Modified Low-Density Determination of the Levels of Antibodies Preparation of a Human Standard for

  1998cites this paper
• Dehydroascorbic acid prevents apoptosis induced by oxidized low-density lipoprotein in human monocyte-derived macrophages.

  1998cites this paper
• Selective Inhibition of Cytosolic Phospholipase A2 in Activated Human Monocytes

  1997cites this paper
• Oxidative modifications of apoB-100 by exposure of low density lipoproteins to HOCL in vitro.

  1997cites this paper
• Inactivation of cathepsin B by oxidized LDL involves complex formation induced by binding of putative reactive sites exposed at low pH to thiols on the enzyme.

  1997cites this paper
• Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.

  1997cites this paper
• Cholesterol

  1997cites this paper
• Antiatherosclerotic and antiatherogenic effects of a calcium antagonist plus statin combination: amlodipine and lovastatin.

  1997cites this paper
• Cellular consequences of the association of apoB lipoproteins with proteoglycans. Potential contribution to atherogenesis.

  1997cites this paper
• Accumulation and metabolism of low density lipoprotein-derived cholesteryl linoleate hydroperoxide and hydroxide by macrophages.

  1997cites this paper
• Effects of garlic on atherosclerosis.

  1997cites this paper
• Structural Changes in Oxidative Modification of Low-Density Lipoprotein: Investigation Using Lipid Peroxidation Products, Surface Charge, and Spectrophotometric Patterns

  1997cites this paper